MCCs
This MCC is characterized by a systemic infection and presence of at least 2 out of SIRS Criteria.
Sepsis
This MCC is a severe, acute life-threatening condition that meets at least one of the following criteria:
A. requiring 6L/min O2 or more, PCO2 >50, RR >30
B. newly requiring mechanical ventilation
C. newly requiring CPAP or BiPAP
D. newly requiring HFNC
E: requiring continuous or Q1-2h neb bronchodilator treatments or MetaNebs
Acute Respiratory Failure
IDA
Iron deficiency anemia
This MCC is characterized by a worsening of a patient's baseline HF that is often treated with diuresis.
HF exacerbation
This MCC is characterized by poor nutritional status and is supported by Aspen Criteria
Severe malnutrition
This MCC is characterized by a systemic infection characterized by 1 SIRS criteria + suspected infection + reason for muted presentation (ie. immunosuppression, cancer, advanced age)
Atypical Sepsis
This MCC is characterized by a requirement of supplemental oxygen for a significant period of time beyond the usual, expected recovery course
Acute post-operative pulmonary insufficiency
AoCD
Anemia of chronic disease
This MCC is characterized by a build-up of fluid in the lungs, which is often treated with diuretics, O2, morphine, or nitrates.
Acute pulmonary edema
This MCC is serious acute complication of diabetes and is characterized by very high blood glucose levels.
DKA
This MCC is characterized by AMS related infection or fluid/electrolyte derangements
Metabolic encephalopathy
This MCC is defined as damage or death of renal tubules, generally occurring after an acute ischemic or toxic event. Evidence includes FENa >2-3%, urea, and BUN/Cr ratio.
ATN
PTX
This MCC is a common complication of brain tumors, hydrocephalus, or massive strokes characterized by midline shift, herniation, and effacement on imaging.
Brain compression
This MCC is characterized by low Hgb, WBCs, and PLT related to a common treatment for cancer patients.
Chemo-related pancytopenia
This MCC is characterized by accumulation of fluid in the extracellular (interstitial) space of the brain and if significant can cause brain compression. This can be seen in stroke, tumor, and inflammatory CNS diseases.
Cerebral or vasogenic edema
This MCC is characterized by diffuse liver injury resulting from acute hypoperfusion. Evidence can include a spike in LFTs
Shock Liver or Ischemic Hepatitis
SBP
Spontaneous bacterial peritonitis
This MCC is an oncologic emergency caused by destruction of cancer cells with release of large amounts of K, P, and nucleic acids into systemic circulation. Commonly occurs after initiation of cytotoxic therapy in patients with aggressive lymphomas.
Tumor lysis syndrome (TLS)
This MCC is characterized by excessive clot formation in blood vessels that can result in organ damage and uncontrollable bleeding.
DIC
This MCC is characterized by ascitic fluid infection without an evident intra-abdominal surgically treatable source. This almost always occurs in patients with ascites and cirrhosis.
Spontaneous bacterial peritonitis
This MCC is characterized by a reduction in blood flow (such as arterial occlusion, venous occlusion, or arterial vasospasm) to small or large bowel. Condition may be treated with surgical laparotomy w/ embolectomy.
Acute bowel ischemia
HE
Hepatic encephalopathy
This MCC is a critical illness characterized by rapid onset of fever, rash, hypotension, and multiorgan system involvement and is due to staphylococcus aureus. Relevant risk factors include recent tampon use, recent surgery, and recent infection.
(Staphylococcal) toxic shock syndrome
This MCC is characterized as a life-threatening muscle infection that develops from an area or trauma or hematogenously (via the blood) from the GI tract. Also known as Clostridial myonecrosis
Gas gangrene